---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-163516"
form_type: "8-K"
ticker: "VRCA"
cik: "0001660334"
company_name: "Verrica Pharmaceuticals Inc."
filed_at: "2023-06-08T23:59:59+00:00"
generated_at: "2026-06-14T05:02:00.005080+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Verrica shareholders re-elect three directors; ratify KPMG as auditor for FY2023

## Summary
- All three director nominees elected: Ballaron (16,697,734 for), Manning (16,965,570), Eichenfield (16,400,406); 17,862,320 broker non-votes.
- Ratification of KPMG LLP as independent auditor for FY2023: 34,915,802 for, 1,088 against, 13,730 abstain.
- 83.46% of 41,852,053 outstanding shares were present or represented at the June 8, 2023 annual meeting.

## SEC filing metadata
- accession: 0001193125-23-163516
- form_type: 8-K
- ticker: VRCA
- cik: 0001660334
- company_name: Verrica Pharmaceuticals Inc.
- filed_at: 2023-06-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1660334/000119312523163516/0001193125-23-163516-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1660334/000119312523163516/d468217d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-163516
- JSON: https://secwatch.observer/filing/0001193125-23-163516.json
- Plain text: https://secwatch.observer/filing/0001193125-23-163516.txt

## Key facts
- Shareholder Votes
  Verrica Pharmaceuticals Inc. shareholders approved Election of three nominees to serve as directors until the 2026 annual meeting of stockholders and until their respective successors are elected and qualified. at the 2023-06-08 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-08
  source text: Proposal No. 1 : Election of three nominees to serve as directors until the 2026 annual meeting of stockholders and until their respective successors are elected and qualified. The votes were cast as follows: Name Votes For Votes Withheld Craig Ballaron 16,697,734 370,566 Paul B. Manning 16,965,570 102,730 Lawrence Eichenfield 16,400,406 667,894 Broker Non-Votes: 17,862,320. All nominees were elected.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1660334/000119312523163516/0001193125-23-163516-index.htm
- Shareholder Votes
  Verrica Pharmaceuticals Inc. shareholders approved Ratification of the appointment of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023. at the 2023-06-08 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-08
  source text: Proposal No. 2 : Ratification of the appointment of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023. The votes were cast as follows: Votes For Votes Against Abstained Ratification of appointment of KPMG LLP 34,915,802 1,088 13,730
  evidence_url: https://www.sec.gov/Archives/edgar/data/1660334/000119312523163516/0001193125-23-163516-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.